Widely used:Recently Viewed
Clear All$0.04
$0.00 (0.00%)As on 07-Apr-2025 16:00EDT
Today’s Range
52 Week Range
Liquidity
Market cap
$----
P/E Ratio
--
P/B Ratio
--
Industry P/E
--
Debt to Equity
--
ROE
--
ROCE
--
Div. Yield
--
Book Value
--
EPS
--
CFO
$--
EBITDA
$--
Net Profit
$--
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Heart Test Laboratories Inc. Warrant (HSCSW)
| 32.89 | -12.09 | -19.68 | 13.96 | -- | -- | -- |
|
BSE Sensex*
| 1.23 | 1.57 | 3.97 | 7.26 | 11.47 | 20.39 | 11.18 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
|
|---|---|---|
|
Heart Test Laboratories Inc. Warrant (HSCSW)
| -39.55 | -82.47 |
|
S&P Small-Cap 600
| 7.01 | 13.89 |
|
BSE Sensex
| 8.10 | 18.74 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to enhance its clinical utility. It is developing artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect... impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction and conventional ECG information in the same test; and MyoVista Insights, a cloud-based platform to host AI-ECG algorithms on an ECG hardware agnostic basis. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas. Address: 550 Reserve Street, Southlake, TX, United States, 76092 Read more
CEO, President & Chairman of the Board of Directors
Mr. Andrew Simpson
CEO, President & Chairman of the Board of Directors
Mr. Andrew Simpson
Headquarters
Southlake, TX
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Heart Test Laboratories Inc Warrant (HSCSW) is $0.04 (NASDAQ) as of 07-Apr-2025 16:00 EDT. Heart Test Laboratories Inc Warrant (HSCSW) has given a return of 13.96% in the last 1 years.
Heart Test Laboratories Inc Warrant (HSCSW) has a market capitalisation of -- as on 07-Apr-2025. As per Value Research classification, it is a Small Cap company.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Heart Test Laboratories Inc Warrant (HSCSW) and enter the required number of quantities and click on buy to purchase the shares of Heart Test Laboratories Inc Warrant (HSCSW).
HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to enhance its clinical utility. It is developing artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction and conventional ECG information in the same test; and MyoVista Insights, a cloud-based platform to host AI-ECG algorithms on an ECG hardware agnostic basis. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas. Address: 550 Reserve Street, Southlake, TX, United States, 76092
The CEO & director of Mr. Andrew Simpson. is Heart Test Laboratories Inc Warrant (HSCSW), and CFO & Sr. VP is Mr. Andrew Simpson.
There is no promoter pledging in Heart Test Laboratories Inc Warrant (HSCSW).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|
| Heart Test Laboratories Inc. Warrant (HSCSW) | Ratios |
|---|---|
|
Return on equity(%)
|
--
|
|
Operating margin(%)
|
--
|
|
Net Margin(%)
|
--
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Heart Test Laboratories Inc Warrant (HSCSW) was $0 Mln.
